A five-antigen Esx-5a fusion delivered as a prime-boost regimen protects against M.tb challenge
<p>The development of tuberculosis (TB) vaccines has been hindered by the complex nature of <em>Mycobacterium tuberculosis</em> (<em>M.tb</em>) and the absence of clearly defined immune markers of protection. While Bacillus Calmette-Guerin (BCG) is cur...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Frontiers Media
2023
|